Cardiolyse

Seed · Healthtech · Helsinki, Finland · Founded 2015 · 11–15 employees

Cardiolyse provides a cloud ECG & HRV analytics platform that enables real-time remote heart health monitoring with medical-grade AI analytics. The platform offers personalized reports, detection of 19 types of arrhythmias, and up to two months data-based prognosis on dangerous heart events. Their CE-certified technology can predict heart attacks and strokes up to 2 months before they occur using patented algorithms. The startup has been selected for multiple accelerator programs including Health Incubator Helsinki, Startup Creasphere by Plug and Play, and EIT Health Catapult. They recently secured an NHS Digital Health Partnership Award for a pilot project with Oxford University Hospital, demonstrating significant traction in the healthcare market.

No open roles listed right now.